Does Standard BioTools Inc (LAB) Stock have a positive outlook following recent trade?
Jefferies raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “a Buy”. The rating was released on April 04, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 1.82% within the last five trades and 6.08% within the last 30 […]
Analysts Projected EPS of $0 in the current quarter for Standard BioTools Inc (NASDAQ:LAB) Stock
Jefferies raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “a Buy”. The rating was released on April 04, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is an average […]
Does Standard BioTools Inc (LAB) Stock have a positive outlook following recent trade?
Jefferies raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “a Buy”. The rating was released on April 04, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is an average […]
Standard BioTools Inc (NASDAQ:LAB) stock Posted Operating Margin of -60.36 percent in Last Year: Is Admissible?
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (LAB) Stock creates opportunities due to its volume and complexity
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (NASDAQ:LAB) Stock Price Settled at $2.68: What’s Resulting?
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
initiated: KeyBanc Capital Markets Recommends Standard BioTools Inc (NASDAQ:LAB) Stock to “an Overweight”
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
